Epzicom combination tablets contain Lamivudine-abacavir sulfate, a combination of two nucleoside reverse transcriptase inhibitors manufactured by ViiV Healthcare, indicated for the treatment of HIV-1 infection. (YJ code: 6250102F1031, standard: 1 tablet)
Epzicom combination tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
